Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

CUSIP: 15117B202

Q3 2019 13F Holders as of 30 Sep 2019

Security identity
Shares outstanding
80,000,000
Holder snapshot
Share change
+242,068
Put/Call ratio
60%
Reported price per share
$2.13
Number of holders
40
Value change
+$465,004
Number of buys
15
Number of sells
18

Security key

15117B202

Report period

Q3 2019

Institutions

40

Top holders

10

Ownership snapshot

Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
RENAISSANCE TECHNOLOGIES LLC
13D/G signal
Evidence rows
15
Latest as of
30 Jun 2019
13F Lead comparable stake: 1.1% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
1.1%
$2,445,000
912,285 shares
30 Jun 2019
Cresset Asset Management, LLC
13F
Company
13F
0.57%
$1,227,000
457,666 shares
30 Jun 2019
BlackRock Finance, Inc.
13F
Company
13F
0.43%
$914,000
340,915 shares
30 Jun 2019
DIMENSIONAL FUND ADVISORS LP
13F
Company
13F
0.42%
$897,000
334,856 shares
30 Jun 2019
VANGUARD GROUP INC
13F
Company
13F
0.37%
$800,000
298,674 shares
30 Jun 2019
ACADIAN ASSET MANAGEMENT LLC
13F
Company
13F
0.33%
$718,000
267,557 shares
30 Jun 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
40
Shares
3,708,146
Rows available
40
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
39
Q3 2019 holders
40
Holder diff
1
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 value Q3 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .